Repeated low-level red light exposure may improve myopia among children: Study
Repeated low-level red light exhibited a stronger impact on myopic children compared with premyopic individuals suggests a study published in the British Journal of Ophthalmology.
A study was done to compare the effects of repeated low-level red light (RLRL) treatment on axial length growth and refractive error changes in myopic and premyopic children. Subjects were assigned randomly to four subgroups: myopia-repeated low-level red light group (M-RL), myopia-control group (M-C), premyopia-repeated low-level red light group (PM-RL) and premyopia-control group (PM-C). Subjects in the RLRL group completed a 12-month treatment composed of a 3 min repeated low-level red light treatment session twice daily, with an interval of at least 4 hours, for 7 days per week. Visits were scheduled before and at 1-month, 3-month, 6-month, 9-month and 12-month follow-up after the treatment.
Repeated-measures analysis of variance was used to compare the spherical equivalent refractive errors (SE) and axial length (AL) changes between the groups across the treatment period.Results: After 12 months of treatment, in the myopia group, SE and AL changes were −0.078±0.375 D and 0.033±0.123 mm for M-RL and −0.861±0.556 D and 0.415±0.171 mm for M-C; in the premyopia group, the progression of SE and AL was −0.181±0.417 D and 0.145±0.175 mm for PM-RL and −0.521±0.436 D and 0.292±0.128 mm for PM-C. PM-RL indicated a lower myopia incidence than PM-C (2.5% vs 19.4%). Additionally, the percentage of AL shortening in the M-RL was higher than that in the PM-RL before the 9-month follow-up. Repeated low-level red light effectively delayed myopia progression in children with myopia and reduced the incidence of myopia in premyopic children. Moreover, repeated low-level red light exhibited a stronger impact on myopic children compared with premyopic individuals.
Liu G, Rong H, Liu Y, et alEffectiveness of repeated low-level red light in myopia prevention and myopia control. British Journal of Ophthalmology. Published Online First: 17 April 2024. doi: 10.1136/bjo-2023-324260
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.